ArticleCancers2025

Impact of Response Assessment Intervals on Survival and Economic Burden in Long-Term Responders to Immunotherapy for Advanced Non-Small-Cell Lung Cancer.

Min Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.